1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Foot Orthotic Insoles Market Analysis: By Type (Custom, Prefabricated); By End User (Sports (Running, Court); Medical (Diabetes, Rheumatoid Arthritis, Plantar Fasciitis, Metatarsalgia, Obesity); Comfort) -With Forecast (2015 - 2020)

Foot orthotic insoles are employed to correct the abnormalities associated with the foot. Foot orthotic insoles work by altering the biomechanics of the foot. The rise in geriatric population over the globe and also lifestyle diseases such obesity, diabetes are the driving factors in this market. The market can be broadly classified into prefabricated and custom foot insoles. Custom Foot Insoles or bespoke foot insoles are prescribed by Podiatrist, Orthotist, Pedorthist, Orthopedist, Chiropractor, or any other health professional with a background in biomechanics, in order to stabilize and correct biomechanical misalignment of the feet and lower limbs. They offer comfortable and functional insole to the customer that improves foot function by accommodating and controlling excessive motion during gait.
The foot orthotic insoles are set to grow at a fast pace, particularly in the APAC region, owing to rise in prevalence of chronic diseases, disposable income as well as increasing awareness about foot orthotic insoles. The Americas and Europe regions are comparatively mature and have an established customer base owing to the rising awareness towards personal healthcare and technological advancements. The market is currently dominated by North America which accounted for about half of the global share. APAC is a promising market and is opening gateways for new manufacturers.

Some of the key players In the global Foot Orthotic Insoles market:
Hanger Inc
Bauerfeind AG
Superfeet and Bayer AG (Dr Scholl’s)
Hange Prosthetics & Orthotics Inc
Superfeet Worldwide Inc
Ottobock Holding GmbH.
They continue to hold the majority share in the market as they are investing in R&D and constantly improving their distribution network.

The market for foot orthotic insoles is classified into two categories based on method of manufacturing and end user and each of these segments are further broken down into sub-segments to give a comprehensive analysis of global foot orthotic insoles market.

The overall market has also been presented from the perspective of different geographic locations and key economies in this market. Competitors are highlighted and market players are profiled with attributes covering company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of the each of the prominent players for 2014 are detailed.

The report also provides a detailed qualitative analysis of the factors responsible for driving and hindering the growth of the foot orthotic insoles market and future opportunities that can propel the market.

Table Of Contents

Foot Orthotic Insoles Market Analysis: By Type (Custom, Prefabricated); By End User (Sports (Running, Court); Medical (Diabetes, Rheumatoid Arthritis, Plantar Fasciitis, Metatarsalgia, Obesity); Comfort) -With Forecast (2015 - 2020)
1. Foot Orthotic Insoles - Market Classification
1.1. Custom Foot Insoles
1.1.1. Customized Insoles
1.1.2. Custom Moulded
1.1.3. 3d Printed
1.2. Prefabricated Foot Insoles
1.3. Foot Orthotic Insoles Prescribers
2. Executive Summary
3. Foot Orthotic Insoles - Market Landscape
3.1. End User Profiling
3.2. Patent Analysis
3.3. Top 5 Companies
4. Foot Orthotic Insoles Market - Market Forces
4.1. Market Drivers
4.1.1. Rapidly Aging Population To Increase Demand For Foot Orthotic Insole Devices
4.1.2. Growing Incidence of Chronic Diseases To Drive The Growth of Orthotics Market
4.1.3. Rapid Urbanization and Associated Lifestyle Diseases Drive The Demand For Foot Orthotic Inserts
4.1.4. Disabilities To Spur The Adoption of Foot Orthotic Insoles
4.1.5. Increased Focus On Improving Quality of Life
4.1.6. Innovations In Production and Modelling Technologies
4.1.7. Rise In Sports Injuries To Drive The Sales of Foot Orthotic Insoles
4.2. Market Restraints
4.2.1. High Cost of Custom-Made Foot Orthotic Insole Devices
4.3. Market Challenges
4.3.1. Healthcare Budget Constraints To Challenge The Growth of Orthotic Device Market
4.3.2. Poor Healthcare Reimbursement and Payment Models To Hamper The Adoption of Orthotics
4.3.3. Consolidation of Market Leaders To Create Significant Growth Challenge For Smaller Companies
5. Foot Orthotic Insoles Market - Strategic Analysis
5.1 Supply Chain Analysis
5.2 Pricing Analysis
6. Foot Orthotic Insoles Market Classification, By End User
6.1. Sports
6.1.1. Running
6.1.2. Court
6.2. Medical
6.2.1. Diabetes
6.2.2. Rheumatoid Arthritis
6.2.3. Plantar Fasciitis
6.2.4. Obesity
6.2.5. Metatarsalgia
6.2.6. Others
6.3. Comfort
7. Foot Orthotic Insoles Market Classification, By Type of Material
7.1. EVA Foam
7.2. Leather
7.3. Polypropylene Thermoplastic
7.4. Nylon
7.5. Others
8. Orthotic Devices - Government Regulations
8.1. North America
8.2. Europe
8.3. Asia-Pacific
8.4. Rest of the World
9. Foot Orthotic Insoles - Geographical Analysis
9.1. Americas
9.1.1. Us
9.1.2. Canada
9.1.3. Others
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. Spain
9.2.4. Italy
9.2.5. France
9.3. Asia - Pacific
9.3.1. Japan
9.3.2. Australia
9.3.3. India
9.3.4. China
9.3.5. Others
9.4. Rest of World
10. Market Entropy
10.1. New Product Launches
10.2. MandAs, Collaborations, JVs and Partnerships
11. Company Profiles
11.1. Acor Orthopedic, Inc.
11.1.1. Business Overview
11.1.2. Products
11.1.3. Financials
11.1.4. Strategy
11.1.5. Developments
11.2. Aetrex Worldwide, Inc.
11.2.1. Business Overview
11.2.2. Products
11.2.3. Financials
11.2.4. Strategy
11.2.5. Developments
11.3. Bledsoe Brace Systems, Inc. - United Orthopedic Group
11.3.1. Business Overview
11.3.2. Products
11.3.3. Financials
11.3.4. Strategy
11.3.5. Developments
11.4. Bauerfeind AG
11.4.1. Business Overview
11.4.2. Products
11.4.3. Financials
11.4.4. Strategy
11.4.5. Developments
11.5. DM Orthotics Ltd.
11.5.1. Business Overview
11.5.2. Products
11.5.3. Financials
11.5.4. Strategy
11.5.5. Developments
11.6. Össur Hf
11.6.1. Business Overview
11.6.2. Products
11.6.3. Financials
11.6.4. Strategy
11.6.5. Developments
11.7. Ottobock Holding Gmbh and Co. Kg
11.7.1. Business Overview
11.7.2. Products
11.7.3. Financials
11.7.4. Strategy
11.7.5. Developments
11.8. Tynor Orthotics Pvt. Ltd.
11.8.1. Business Overview
11.8.2. Products
11.8.3. Financials
11.8.4. Strategy
11.9. Footbalance System Ltd.
11.9.1. Business Overview
11.9.2. Financials
11.9.3. Products
11.9.4. Developments
11.10. Amfit Inc.
11.10.1. Business Overview
11.10.2. Financials
11.10.3. Products
11.10.4. Developments
11.11. SOLS Systems
11.11.1. Business Overview
11.11.2. Financials
11.11.3. Products
11.11.4. Developments
11.12. FootMindBody
11.12.1. Business Overview
11.12.2. Financials
11.12.3. Products
11.12.4. Developments
11.13. Solo Laboratories, Inc.
11.13.1. Business Overview
11.13.2. Financials
11.13.3. Products
11.13.4. Developments
11.14. Kintec Lab Services
11.14.1. Business Overview
11.14.2. Financials
11.14.3. Products
11.14.4. Developments
11.15. Marathon Orthotics, Inc.
11.15.1. Business Overview
11.15.2. Financials
11.15.3. Products
11.15.4. Developments
11.16. Comfortfit Orthotic Labs Inc.
11.16.1. Business Overview
11.16.2. Financials
11.16.3. Products
11.16.4. Developments
11.17. Flexor S.A.
11.17.1. Business Overview
11.17.2. Financials
11.17.3. Products
11.17.4. Developments
11.18. Emkiro Inc.
11.18.1. Business Overview
11.18.2. Financials
11.18.3. Products
11.18.4. Developments
11.19. Cascade Dafo, Inc.
11.19.1. Business Overview
11.19.2. Financials
11.19.3. Products
11.19.4. Developments
11.20. Solescience Inc.
11.20.1. Business Overview
11.20.2. Financials
11.20.3. Products
11.20.4. Developments
11.21. Bayer Healthcare LLC
11.21.1. Business Overview
11.21.2. Products
11.21.3. Financials
11.21.4. Developments
11.22. Doctorinsole
11.22.1. Business Overview
11.22.2. Financials
11.22.3. Products
11.22.4. Developments
11.23. The Foot Lab
11.23.1. Business Overview
11.23.2. Products
11.23.3. Financials
11.23.4. Developments
11.24. RSL Steeper
11.24.1. Business Overview
11.24.2. Financials
11.24.3. Products
11.24.4. Developments
11.25. Algeo Limited
11.25.1. Business Overview
11.25.2. Financials
11.25.3. Products
11.25.4. Developments
11.26 Blatchford Clinical Services
11.26.1. Business Overview
11.26.2. Financials
11.26.3. Products
11.26.4. Developments
11.27. Arden Orthotics Ltd
11.27.1. Business Overview
11.27.2. Financials
11.27.3. Products
11.27.4. Developments
11.28. Bolton Bros
11.28.1. Business Overview
11.28.2. Financials
11.28.3. Products
11.28.4. Developments
11.29. Salts Techstep
11.29.1. Business Overview
11.29.2. Products
11.29.3. Developments
11.30. Superfeet Worldwide, Inc.
11.30.1. Business Overview
11.30.2. Financials
11.30.3. Products
11.30.4. Developments
11.31. DJO Global Inc.
11.31.1. Business Overview
11.31.2. Products
11.31.3. Financials
11.31.4. Strategy
11.31.5. Developments
11.32 Hanger Prosthetics and Orthotics Inc.
11.32.1. Business Overview
11.32.2. Products
11.32.3. Financials
11.32.4. Strategy
11.32.5. Developments
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Research Methodology

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • August 2016
  • by GBI Research

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Global Markets for Diabetes Therapeutics and Diagnostics

Global Markets for Diabetes Therapeutics and Diagnostics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Analyze the market for drugs used in the treatment of diabetes, it's technology and the industry as a whole - Identify important trends and provide sales forecasts by product categories ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.